Medicare could have saved its beneficiaries nearly $3 million a year if it adopted a stricter policy for lower prices for Part B drugs, a Department of Health and Human Services (HHS) watchdog found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback